In the challenging divulgence of epidemics, the occurrence of hospital-acquired infections (HAIs) from multidrug-resistant organisms (MDROs) emerges as a significant difficulty confronting global healthcare systems. Such infections generally occur 48 hours after hospital admission or post-discharge and result in prolonging hospitalization rates, enhancing medical expenses, and amplifying mortality rates. Some of the most menacing bacteria posing threats in this context are named under the ESKAPE group, a group notorious for evading antibiotic shields.
An exhaustive retrospective analysis spanning eight years at a Shanghai-based hospital catered to understanding the impacts of infection policies during the COVID-19 outbreak on the incidence augmentation of HAIs. A succession of lab samples gathered monthly over the course of the analysis from January 2016 to December 2023 showcased a total of 6763 MDRO cultures derived from 4549 patients. The bed occupancy was utilized to calculate monthly HAI incidence rates per 10,000. By segregating the study into distinct periods of pre-control, in-control, and post-control cohorts, significant observations were made in respective HAI incidence rates and their comparative trends.
In the examined periods, an overall downward trend was noticed in the HAI incidence, especially in the post-control phase promisingly suggesting the potential reinforcements of infection control measures during the COVID-19 pandemic era. However, the substantial need for honing prevention, control strategies against different pathogens for future epidemics also underlining the importance of continuous surveillance and monitoring was emphasized.
Exploring the demographic divides, the median ages registered a slight upward shift across the three cohorts from 62.79 years to 66.08 years while the male dominance was present in all periods at varying percentages. The focus here is on addressing the specific pathogens defining MDROs which include methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Acinetobacter baumannii (CRAB), carbapenem-resistant Pseudomonas aeruginosa (CRPA), carbapenem-resistant Klebsiella pneumoniae (CRKP) and carbapenem-resistant Enterobacterales (CRE).
From the analysis across all infections and MDROs, a downward infection incidence was observed in the post-control cohort, this implication held for MRSA and CRAB pathogens while the trend unveiled an immediate increase in infections caused by both these pathogens consequent to the relaxing of COVID-19 policies. In recognizing the pathogens displaying upward infection trends across different periods, the pre-control cohort echoed the CRKP and CRE pathogens, meanwhile, the CRPA pathogen dominated the upward trend in the in-control cohort.
This eight-year scholarly research thus aids in unraveling the intertwining dynamics of HAIs, MDROs, and infection control policies during a global epidemic. While delineating the immediate and gradual effects of regulatory interventions in addressing healthcare infections, it further invites more in-depth exploration into the study of drug-resistant bacteria.